Ask AI
Kevin Kalinsky

Kevin Kalinsky, MD, MS, FASCO

Professor of Medicine
Louisa and Rand Glenn Family Chair in Breast Cancer Research
Winship Cancer Institute
Emory University
Atlanta, Georgia

Explore Activities by Kevin Kalinsky

Title
Format
Credit Type
Credits
An Expert’s Guide to ASCO 2025: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Adjuvant Therapy for HER2-Negative Early Breast Cancer: Interactive Decision Support Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Key Studies in Breast Cancer: Independent Conference Coverage of the 2024 ASCO Annual Meeting

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Clinical Dilemmas When Selecting Adjuvant Therapy for HER2-Negative Early-Stage Breast Cancer

Content Format:

Clinical Thought

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Conference to Clinic: Breast Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Conference to Clinic: Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Comparison of expert treatment recommendations vs community healthcare providers: analysis from an online decision support tool for metastatic breast cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
An Expert’s Guide to ASCO 2024: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Expert Perspectives on Novel and Emerging HER2-Directed and TROP-2‒Targeted ADCs for Advanced Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Sequencing Treatment in HER2-Positive Metastatic Breast Cancer

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.75
Sequencing Treatment in HER2-Positive Metastatic Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Making Treatment Decisions for Metastatic Breast Cancer: An Interactive Decision Support Tool for Patients

Content Format:

Tool

Credit Type:

--

Credits:

--
Next-Generation Endocrine Therapies for ER+/HER2- Breast Cancer Care: Key Takeaways From Our Recent Symposium in San Antonio

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Next-Generation Endocrine Therapies: Opportunities in ER+/HER2- Breast Cancer Care

Content Format:

Video

Credit Type:

AMA

Credits:

1.25
New Options in High-Risk Early Breast Cancer

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

1.00
My Experience Managing Key Adverse Events With Oral Targeted Therapy for High-Risk Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Navigating Endocrine Therapy and Resistance in ER+/HER2- Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Oral SERDs and Novel Endocrine Therapies: Reshaping the Treatment Landscape for ER+/HER2- Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
New Options in High-Risk Early Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Treatment Guidance for Metastatic Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
(Neo)Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Review of Treatment for HER2-Negative Early Breast Cancer

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Expert Review of Treatment for HER2-Negative Early Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Healthcare Professional Checklist for Patient Communication in HER2-Negative Early Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
An Interactive Treatment Decision Tool for HER2-Negative Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
(Neo) Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
New Data, New Opportunities, and New Clinical Challenges Using Immunotherapies for TNBC

Content Format:

Video

Credit Type:

AMA

Credits:

1.25
How I Sequence Recently Approved Immunotherapies in Advanced TNBC With vs Without BRCA Mutation

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ExpressPoints: New Opportunities and Clinical Challenges Using Immunotherapies for TNBC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Antibody–Drug Conjugates in TNBC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--